Treatment for advanced poorly differentiated neuroendocrine carcinoma should parallel treatments used for small-cell lung cancer.
晚期低分化神经内分泌癌的治疗应该与小细胞肺癌的治疗进行对照实验。
Patients and METHODS: Patients eligible for this multicenter, phase II trial had metastatic poorly differentiated neuroendocrine carcinoma and had received no previous treatment.
病人和方法：符合这次多中心二期实验的病人患有转移性低分化神经内分泌癌，并且之前未接受任何治疗。
Patients and METHODS: Patients eligible for this multicenter, phase II trial had metastatic poorly differentiated neuroendocrine carcinoma and had received no previous treatment.
病人和方法：符合这次多中心二期实验的病人患有转移性低分化神经内分泌癌，并且之前未接受任何治疗。
应用推荐